Literature DB >> 14764279

Hyperglycemia with antipsychotic treatment.

Roopa Sathyaprakash1, Robert R Henry.   

Abstract

Diabetes and mental disorders are common chronic illnesses in the United States. Recently, the introduction of a new class of atypical antipsychotic medications has been a major treatment advance for patients with mental disorders. Because of increased use of atypical antipsychotic medications, new and unanticipated side effects have often appeared. Treatment-emergent diabetes has been described for conventional and atypical antipsychotics. People with schizophrenia may be at increased risk for type 2 diabetes because of the side effects of antipsychotic medication, underlying predisposition, and less healthy lifestyles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764279     DOI: 10.1007/s11892-004-0010-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  60 in total

1.  Diabetic ketoacidosis with olanzapine treatment.

Authors:  B Gatta; V Rigalleau; H Gin
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

2.  New-onset diabetes mellitus associated with quetiapine.

Authors:  R M Procyshyn; S Pande; G Tse
Journal:  Can J Psychiatry       Date:  2000-09       Impact factor: 4.356

3.  PHENOTHIAZINE DERIVATIVES AND GLUCOSE METABOLISM.

Authors:  G A ARNESON
Journal:  J Neuropsychiatr       Date:  1964-02

4.  Carbohydrate metabolism in brain disease. II. Glucose metabolism in Schizophrenic, manic-depressive, and involutional psychoses.

Authors:  D H HENNEMAN; M D ALTSCHULE; R M GONCZ
Journal:  AMA Arch Intern Med       Date:  1954-09

5.  Glucose tolerance in chronic schizophrenia and senile states.

Authors:  W SIMON; J T GARVEY
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-06

6.  Diabetes mellitus in schizophrenic patients.

Authors:  S Mukherjee; P Decina; V Bocola; F Saraceni; P L Scapicchio
Journal:  Compr Psychiatry       Date:  1996 Jan-Feb       Impact factor: 3.735

7.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

8.  Severe hyperglycemia associated with high doses of clozapine.

Authors:  A Kamran; P M Doraiswamy; J L Jane; E B Hammett; L Dunn
Journal:  Am J Psychiatry       Date:  1994-09       Impact factor: 18.112

9.  The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia.

Authors:  M Brecher; I W Rak; K Melvin; A M Jones
Journal:  Int J Psychiatry Clin Pract       Date:  2000       Impact factor: 1.812

10.  Dosing the antipsychotic medication olanzapine.

Authors:  C B Nemeroff
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

View more
  2 in total

Review 1.  Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.

Authors:  Hua Jin; Jonathan M Meyer; Sunder Mudaliar; Dilip V Jeste
Journal:  Schizophr Res       Date:  2008-01-18       Impact factor: 4.939

2.  Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.

Authors:  Lucas Lecourtier; Houman Homayoun; Gilles Tamagnan; Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2007-05-23       Impact factor: 13.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.